thelancet.com
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Combining radiotherapy with standard of care plus abiraterone improves radiographic
progression-free survival and castration resistance-free survival, but not overall
survival in patients with low-vol...